Evidence map›Paper›PMID 40971247›Full record

ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2025

A Retrospective Cohort Study of Physical Activity and Survival in Patients Treated with Immune Checkpoint Inhibitors.

Nathan H Parker, Jairo D Ramos, Ahmad A Tarhini, Michael J Schell, Kathleen M Egan, Peter A Kanetsky

Abstract read
In one paragraph

Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Nathan H ParkerDepartment of Health Outcomes and Behavior, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida.ORCID 0000-0002-8947-7942
Jairo D RamosDepartment of Cancer Epidemiology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida.ORCID 0000-0003-1293-3839
Ahmad A TarhiniDepartment of Cutaneous Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida.ORCID 0000-0002-3193-9702
Michael J SchellDepartment of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida.ORCID 0000-0003-4594-6601
Kathleen M EganDepartment of Cancer Epidemiology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida.ORCID 0000-0001-8772-6979
Peter A KanetskyDepartment of Cancer Epidemiology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida.ORCID 0000-0002-5567-9618

Funding

TRANSLATIONAL RESEARCHP30CA076292 · NCI · UNIVERSITY OF SOUTH FLORIDA · PI John L. Cleveland · 1998 to 2026
$93.5M
NCI NIH HHS P30 CA076292
6 · The paper itself

Abstract

backgroundThe impact of physical activity in patients with cancer treated with immune checkpoint inhibitors (ICI), both of which affect outcomes via modulating the immune system, is unclear. We investigated associations between self-reported, pretreatment physical activity and survival in a series of patients with cancer treated with ICI.

methodsThis retrospective cohort study included 930 patients treated with ICI who previously reported physical activity and had good performance status at treatment initiation. Hazards of death associated with increasing quartile of physical activity, measured as weekly metabolic equivalent of task minutes derived from the International Physical Activity Questionnaire (IPAQ), were estimated by multivariable Cox proportional hazards models adjusting for covariates. Alternative measures of physical activity based on IPAQ and consensus guidelines were also assessed.

resultsIncreasing physical activity quartile was associated with a decreased adjusted hazard of death [adjusted HR (aHR) per one quartile increase, 0.89; 95% confidence interval (CI), 0.82-0.96]. Patients in the third and top quartile had a 24% (aHR = 0.76; 95% CI, 0.59-0.97) and 28% (aHR = 0.72; 95% CI, 0.55-0.93) reduced hazard of death compared with the bottom quartile, respectively. Results based on IPAQ and consensus guidelines and results from sensitivity analyses support findings from main analyses.

conclusionsPretreatment physical activity is associated with increased survival among patients with cancer treated with ICI. Observational studies incorporating objective measurement and randomized interventional trials are needed to further establish the role of physical activity in improving ICI outcomes. IMPACT: Physical activity may be a promising interventional strategy to accompany ICI therapy to improve patient outcomes.

Indexed as

ExerciseImmune Checkpoint InhibitorsNeoplasmsAgedFemaleHumansMaleMiddle AgedRetrospective StudiesImmune Checkpoint Inhibitors

Identifiers

PMID40971247
PMCPMC12579459

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.